Christine Mikail Cvijic, President and CFO at Neurogene Inc. (NGNE), sold 4,800 shares at $25.11 ($121K) on 2026-02-27, disclosed to the SEC on 2026-03-03.
Scheduled sale ($121k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NGNE | SELL | 2026-05-08 | $300K | — | Filing → |
| NGNE | SELL | 2026-03-30 | $111K | — | Filing → |
| NGNE | SELL | 2026-03-17 | $168K | — | Filing → |